MedTrace Logo

PET Fibrin Imaging of DVT and PE

NCT04022915 · Status: TERMINATED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2026-03-18

Study results available
· View outcomes & findings →

Summary

This study aims to investigate a novel positron emission tomography(PET)-probe for imaging of fresh intravascular blood clots in pulmonary embolism (PE) and deep venous thrombosis (DVT).

Conditions

Interventions

DRUG

64Cu-FBP8

Up to 10 mCi (millicurie) 64Cu-FBP8 will be administered to each subject.

DIAGNOSTIC_TEST

PET-CT imaging

All subjects will undergo PET-CT imaging after administration of 64Cu-FBP8.

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • Peter Caravan

    lead OTHER

Principal Investigators

  • Tilo Winkler, PhD · Massachusetts General Hospital

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-13
Primary Completion
2022-07-19
Completion
2024-08-26
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04022915 on ClinicalTrials.gov